Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective

Area of Science:

• Endocrinology
• Bone Biology
• Mineral Metabolism

Background:

• Hyperparathyroidism involves parathyroid hormone (PTH) overproduction, either autonomously or due to physiological stimuli.
• The calcium-parathyroid-vitamin D axis significantly impacts bone health in both normal physiology and disease states.

Purpose of the Study:

• To review recent findings on the role of the calcium-parathyroid-vitamin D axis in bone health.
• To elucidate the differential effects of PTH on cortical and trabecular bone microarchitecture.
• To highlight the fracture risks associated with various forms of hyperparathyroidism.

Main Methods:

• Review of current literature on hyperparathyroidism and bone health.
• Analysis of PTH's effects on bone microarchitecture and fracture incidence.
• Comparison of fracture risks in primary and secondary hyperparathyroidism, considering vitamin D status.

Main Results:

• PTH exerts distinct effects on cortical (resorption) and trabecular (anabolic/resorption) bone compartments.
• Vertebral fractures are common in primary hyperparathyroidism (PHPT), occurring at higher bone mineral density (BMD) than in osteoporosis, suggesting microarchitectural changes.
• Secondary hyperparathyroidism with vitamin D deficiency increases bone susceptibility to fractures.
• Normocalcemic PHPT is also linked to elevated fracture risk.

Conclusions:

• Hyperparathyroidism is detrimental to bone health, increasing fracture risk.
• Bone microarchitecture changes, not fully captured by BMD, are critical in hyperparathyroidism-related fractures.
• Normalization of PTH levels, via parathyroidectomy in PHPT or addressing underlying causes in secondary hyperparathyroidism, is essential for preserving bone integrity.